Biomedical Engineering Society

Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$7,497,337
Investments
64%
Cash & Equivalents
29%
Prepaid Expenses
5%
Other Assets
1%
Receivables (Non-Related)
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$1,316,044
Deferred Revenue
73%
Payables & Accruals
20%
Other Liabilities
7%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$877,116
$2,159,073
+146%
Receivables (Non-Related)
$411,815
$53,186
-87%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$213,651
$377,061
+76%
Investments
$4,164,994
$4,797,624
+15%
Property, Plant, & Equipment (net)
$12,967
$8,315
-36%
Other Assets
$194,310
$102,078
-47%
Total Assets
$5,874,853
$7,497,337
+28%
Liabilities
2023
2024
Change
Payables & Accruals
$180,224
$261,856
+45%
Grants Payable
-
-
-
Deferred Revenue
$1,139,878
$958,162
-16%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$206,852
$96,026
-54%
Total Liabilities
$1,526,954
$1,316,044
-14%
Net assets
2023
2024
Change
Restricted Net Assets
$1,515,971
$1,545,028
+2%
Unrestricted Net Assets
$2,831,928
$4,636,265
+64%
Net assets
2023
2024
Change
Net assets
+$4,347,899
+$6,181,293
+42%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)